LUPPI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 10.228
EU - Europa 7.244
AS - Asia 3.926
SA - Sud America 593
Continente sconosciuto - Info sul continente non disponibili 178
AF - Africa 78
OC - Oceania 12
Totale 22.259
Nazione #
US - Stati Uniti d'America 9.959
IT - Italia 4.001
SG - Singapore 1.319
GB - Regno Unito 1.244
CN - Cina 913
VN - Vietnam 436
BR - Brasile 435
SE - Svezia 410
HK - Hong Kong 383
DE - Germania 314
FR - Francia 287
FI - Finlandia 217
BD - Bangladesh 213
UA - Ucraina 194
RU - Federazione Russa 187
CA - Canada 138
TR - Turchia 123
NL - Olanda 119
IN - India 115
KR - Corea 86
ID - Indonesia 64
BG - Bulgaria 63
AR - Argentina 55
MX - Messico 50
JP - Giappone 46
IQ - Iraq 43
IE - Irlanda 35
BE - Belgio 32
VE - Venezuela 25
PL - Polonia 23
ZA - Sudafrica 23
EC - Ecuador 22
ES - Italia 21
PK - Pakistan 20
AE - Emirati Arabi Uniti 16
IR - Iran 15
CO - Colombia 14
SA - Arabia Saudita 14
CL - Cile 13
CR - Costa Rica 13
LT - Lituania 12
MY - Malesia 12
NP - Nepal 12
AU - Australia 11
CH - Svizzera 11
MA - Marocco 11
KE - Kenya 10
PH - Filippine 10
PY - Paraguay 10
TW - Taiwan 10
AT - Austria 9
HN - Honduras 9
JM - Giamaica 9
PR - Porto Rico 9
TH - Thailandia 9
TN - Tunisia 9
AZ - Azerbaigian 8
HR - Croazia 8
JO - Giordania 8
PE - Perù 8
CW - ???statistics.table.value.countryCode.CW??? 7
GT - Guatemala 7
IL - Israele 7
LV - Lettonia 7
PT - Portogallo 7
SV - El Salvador 7
DK - Danimarca 6
EU - Europa 6
LB - Libano 6
NI - Nicaragua 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EE - Estonia 5
KZ - Kazakistan 5
NO - Norvegia 5
CY - Cipro 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
UZ - Uzbekistan 4
BZ - Belize 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
KW - Kuwait 3
SC - Seychelles 3
SI - Slovenia 3
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
LU - Lussemburgo 2
MN - Mongolia 2
Totale 22.060
Città #
Ashburn 1.190
Southend 887
Singapore 869
Fairfield 794
Santa Clara 787
San Jose 542
Chandler 478
Woodbridge 476
Houston 398
Hong Kong 371
Council Bluffs 316
Ann Arbor 308
Milan 300
Rome 289
Seattle 279
Wilmington 266
Jacksonville 253
Cambridge 244
Dearborn 233
Nyköping 222
Beijing 204
London 164
New York 164
Helsinki 162
Hefei 155
Modena 155
Los Angeles 148
Ho Chi Minh City 121
Chicago 114
Hanoi 113
San Diego 101
The Dalles 95
Florence 76
Dallas 73
Naples 72
Seoul 69
Shanghai 65
Columbus 63
Sofia 60
Bologna 58
Buffalo 57
Princeton 57
Izmir 55
Palermo 54
São Paulo 54
Eugene 52
Catania 49
Jakarta 47
Lauterbourg 47
Salt Lake City 47
Bari 46
Orem 44
Moscow 43
Redwood City 40
Munich 39
Phoenix 37
Turin 35
Bremen 33
Genoa 33
Verona 33
Boardman 32
Montreal 30
Tokyo 30
Brussels 29
Toronto 29
Atlanta 28
Chennai 27
Frankfurt am Main 27
Cagliari 25
Padova 25
Da Nang 22
Mexico City 21
Baghdad 20
Salerno 20
Falls Church 19
Guangzhou 19
Mountain View 19
Brooklyn 18
Denver 18
Haiphong 18
Tampa 18
Bergamo 17
Boston 17
Pisa 17
Brescia 16
Manchester 16
Parma 16
Reggio Emilia 16
Des Moines 15
Elk Grove Village 15
Fremont 15
Treviso 15
Warsaw 15
Turku 14
Buenos Aires 13
Cinisello Balsamo 13
Dublin 13
Miano 13
Mumbai 13
Dhaka 12
Totale 13.411
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.906
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 529
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 501
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 462
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 451
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 441
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 404
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 401
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 396
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 381
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 379
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 375
Complex chronic co-morbidities of COPD 373
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 371
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 363
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 358
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 355
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 352
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 346
Treatment of chronic obstructive pulmonary disease and its comorbidities 344
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 338
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 336
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 333
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 329
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 326
Prognostic role of clusterin in resected adenocarcinomas of the lung. 324
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 323
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 320
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 318
Clusterin (CLU) and lung cancer 317
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 316
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 313
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 309
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 308
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 304
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 303
Management of Idiopathic Pulmonary Fibrosis 303
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 290
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 275
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 274
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 270
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 270
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 263
Challenges in idiopathic interstitial lung disease 261
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 259
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 250
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 240
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 223
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 220
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 211
Therapeutic approaches to idiopathic pulmonary fibrosis 198
Medicina personalizzata e fibrosi polmonare idiopatica 183
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 180
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 180
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 167
Malattie infiltrative diffuse del polmone 166
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 146
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational “EMERGE” study 144
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 142
Efectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter Study 136
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 134
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 85
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project 83
Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study 74
Multidisciplinary management of interstitial lung disease in autoimmune rheumatic diseases: an Italian Delphi consensus 27
Totale 22.259
Categoria #
all - tutte 72.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.143 0 0 0 107 62 92 64 84 171 100 260 203
2022/20232.122 193 178 119 181 203 237 123 198 239 112 192 147
2023/20242.061 115 139 156 199 270 224 201 225 60 95 174 203
2024/20253.315 198 112 115 263 593 432 282 211 338 136 270 365
2025/20265.719 345 191 395 599 902 443 771 254 557 519 406 337
2026/20271.708 204 514 406 584 0 0 0 0 0 0 0 0
Totale 22.259